No. 345-Primary Dysmenorrhea Consensus Guideline

Akerland, 1979, Pathophysiology of dysmenorrhea, Acta Obstet Gynecol, 87, 27, 10.3109/00016347909157786 Rosenwaks, 1980, Menstrual pain: its origin and pathogenesis, J Reprod Med, 25, 207 Chapron, 2011, Markers of adult endometriosis detectable in adolescence, J Pediatr Adolesc Gynecol, 24, S7, 10.1016/j.jpag.2011.07.006 Jamieson, 1996, The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices, Obstet Gynecol, 87, 55, 10.1016/0029-7844(95)00360-6 Ng, 1992, A prevalence study of dysmenorrhoea in female residents aged 15-54 years in Clementi Town, Singapore, Ann Acad Med Singapore, 21, 323 Strinic, 2003, Anthropological and clinical characteristics in adolescent women with dysmenorrhea, Coll Antropol, 27, 707 Andersch, 1982, An epidemiologic study of young women with dysmenorrhea, Am J Obstet Gynecol, 144, 655, 10.1016/0002-9378(82)90433-1 Hirata, 2002, [Relationship between the frequency of menstrual pain and bodyweight in female adolescents], Nihon Koshu Eisei Zasshi, 49, 516 Pawlowski, 2004, Prevalence of menstrual pain in relation to the reproductive life history of women from the Mayan rural community, Ann Hum Biol, 31, 1, 10.1080/03014460310001602072 Pullon, 1988, Prevalence of dysmenorrhoea in Wellington women, N Z Med J, 101, 52 Zondervan, 1998, The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review, Br J Obstet Gynaecol, 105, 93, 10.1111/j.1471-0528.1998.tb09357.x Hillen, 1999, Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment, J Adolesc Health, 25, 40, 10.1016/S1054-139X(98)00147-5 Burnett, 2005, Prevalence of primary dysmenorrhea in Canada, J Obstet Gynaecol Can, 27, 765, 10.1016/S1701-2163(16)30728-9 Weissman, 2004, The natural history of primary dysmenorrhoea: a longitudinal study, BJOG, 111, 345, 10.1111/j.1471-0528.2004.00090.x Sundell, 1990, Factors influencing the prevalence and severity of dysmenorrhoea in young women, Br J Obstet Gynaecol, 97, 588, 10.1111/j.1471-0528.1990.tb02545.x Parazzini, 1994, Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea, Epidemiology, 5, 469, 10.1097/00001648-199407000-00016 Ju, 2014, The prevalence and risk factors of dysmenorrhea, Epidemiol Rev, 36, 104, 10.1093/epirev/mxt009 Harlow, 1996, A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women, Br J Obstet Gynaecol, 103, 1134, 10.1111/j.1471-0528.1996.tb09597.x Kritz-Silverstein, 1999, The association of behavior and lifestyle factors with menstrual symptoms, J Womens Health Gend Based Med, 8, 1185, 10.1089/jwh.1.1999.8.1185 Chen, 2000, Prospective study of exposure to environmental tobacco smoke and dysmenorrhea, Environ Health Perspect, 108, 1019, 10.1289/ehp.001081019 Alonso, 2001, Disruptions of social relationships accentuate the association between emotional distress and menstrual pain in young women, Health Psychol, 20, 411, 10.1037/0278-6133.20.6.411 Iacovides, 2015, What we know about primary dysmenorrhea today: a critical review, Hum Reprod Update, 21, 762, 10.1093/humupd/dmv039 Balik, 2014, Is there a relationship between mood disorders and dysmenorrhea?, J Pediatr Adolesc Gynecol, 27, 371, 10.1016/j.jpag.2014.01.108 Coco, 1999, Primary dysmenorrhea, Am Fam Physician, 60, 489 Iglesias, 1999, Menstrual cycle abnormalities: diagnosis and management, Adolesc Med, 10, 255 Banikarim, 2000, Prevalence and impact of dysmenorrhea on Hispanic female adolescents, Arch Pediatr Adolesc Med., 154, 1226, 10.1001/archpedi.154.12.1226 Emans, 2005 Twigg, 2002, Dysmenorrhoea, Curr Obstet Gynaecol, 12, 341, 10.1054/cuog.2002.0290 Janssen, 2013, Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review, Hum Reprod Update, 19, 570, 10.1093/humupd/dmt016 Campbell, 1997, Use of medication by adolescents for the management of menstrual discomfort, Arch Pediatr Adolesc Med, 151, 905, 10.1001/archpedi.1997.02170460043007 Jarrell, 2005, Consensus guidelines for the management of chronic pelvic pain, J Obstet Gynaecol Can, 27, 869, 10.1016/S1701-2163(16)30993-8 Taran, 2013, Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy, Geburtshilfe Frauenheilkd, 73, 924, 10.1055/s-0033-1350840 Wu, 2012, Effects of noninvasive electroacupuncture at Hegu (LI4) and Sanyinjiao (SP6) acupoints on dysmenorrhea: a randomized controlled trial, J Altern Complement Med, 18, 137, 10.1089/acm.2010.0506 Laufer MR. Helping “adult gynecologists” diagnose and treat adolescent endometriosis: reflections on my 20 years of personal experience. J Pediatr Adolesc Gynecol 2011 Oct:24(5 Suppl):S13-7. http://dx.doi.org/10.1016/j.jpag.2011.07.005. Schroeder, 2001, Chronic pelvic pain: medical and surgical approaches Laufer, 1997, Identification of clear vesicular lesions of atypical endometriosis: a new technique, Fertil Steril, 68, 739, 10.1016/S0015-0282(97)00318-X Ali, 2007, Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea, Curr Med Res Opin, 23, 841, 10.1185/030079907X182239 Di Girolamo, 2004, Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?, Expert Opin Pharmacother, 5, 561, 10.1517/14656566.5.3.561 Marjoribanks, 2015, Nonsteroidal anti-inflammatory drugs for dysmenorrhoea, Cochrane Database Syst Rev, CD001751 Ekstrom, 1992, Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment—effect on uterine contractility, Br J Obstet Gynaecol, 99, 680, 10.1111/j.1471-0528.1992.tb13855.x Chan, 1980, Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy, Adv Prostaglandin Thromboxane Res, 8, 1443 Creatsas, 1990, Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives, Eur J Obstet Gynecol Reprod Biol, 36, 292, 10.1016/0028-2243(90)90213-K Ekstrom, 1989, Effect of an oral contraceptive in primary dysmenorrhea—changes in uterine activity and reactivity to agonists, Contraception, 40, 39, 10.1016/0010-7824(89)90026-7 Milsom, 1990, The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea, Contraception, 42, 497, 10.1016/0010-7824(90)90078-A Robinson, 1992, Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic, Am J Obstet Gynecol, 166, 578, 10.1016/0002-9378(92)91676-2 Larsson, 1992, The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status, Contraception, 46, 327, 10.1016/0010-7824(92)90095-B Ulstein, 1984, Clinical experience with a triphasic oral contraceptive, Acta Obstet Gynecol Scand, 63, 233, 10.3109/00016348409155503 Weber-Diehl, 1992, Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial, Contraception, 46, 19, 10.1016/0010-7824(92)90128-G Gauthier, 1992, Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol, Acta Obstet Gynecol Scand Suppl, 156, 27, 10.3109/00016349209156512 Brill, 1991, Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users, Contraception, 43, 101, 10.1016/0010-7824(91)90037-G Callejo, 2003, Effect of a low-dose oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel on dysmenorrhea, Contraception, 68, 183, 10.1016/S0010-7824(03)00132-X Proctor, 2001, Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhea, Cochrane Database Syst Rev, CD002120 Hendrix, 2002, Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive, Contraception, 66, 393, 10.1016/S0010-7824(02)00414-6 Harada, 2011, Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial, Fertil Steril, 95, 1928, 10.1016/j.fertnstert.2011.02.045 Sulak, 2002, Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms, Am J Obstet Gynecol, 186, 1142, 10.1067/mob.2002.122988 Vercellini, 2002, Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis, Fertil Steril, 77, 52, 10.1016/S0015-0282(01)02951-X Vercellini, 2003, Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen, Fertil Steril, 80, 560, 10.1016/S0015-0282(03)00794-5 Dmitrovic, 2012, Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial, Obstet Gynecol, 119, 1143, 10.1097/AOG.0b013e318257217a Edelman, 2014, Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception, Cochrane Database Syst Rev, CD004695 Momoeda, 2014, Does the presence of coexisting diseases modulate the effectiveness of a low-dose estrogen/progestin, ethinylestradiol/drospirenone combination tablet in dysmenorrhea? Reanalysis of two randomized studies in Japanese women, Int J Womens Health, 6, 989 Schwallie, 1974, The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review, Contraception, 10, 181, 10.1016/0010-7824(74)90073-0 1998 Schwallie, 1973, Contraceptive use—efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days, Fertil Steril, 24, 331, 10.1016/S0015-0282(16)39669-8 Polaneczky, 1996, Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Fam Plann Perspect, 28, 174, 10.2307/2136195 Belsey, 1991, Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation, Adv Contracept, 7, 257, 10.1007/BF01849416 Said, 1986, Contraception, 34, 223, 10.1016/0010-7824(86)90004-1 Al-Jefout, 2016, Continuous norethisterone acetate versus cyclical drospirenone 3 mg/ethinyl estradiol 20 μg for the management of primary dysmenorrhea in young adult women, J Pediatr Adolesc Gynecol, 29, 143, 10.1016/j.jpag.2015.08.009 Strowitzki, 2010, Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial, Hum Reprod, 25, 633, 10.1093/humrep/dep469 Tanmahasamut, 2012, Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial, Obstet Gynecol, 119, 519, 10.1097/AOG.0b013e31824264c3 Sheng, 2009, The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis, Contraception, 79, 189, 10.1016/j.contraception.2008.11.004 Imai, 2014, Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review, Clin Exp Obstet Gynecol, 41, 495, 10.12891/ceog17042014 Lindh, 2013, The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study, Hum Reprod, 28, 1953, 10.1093/humrep/det101 Heikinheimo, 2012, Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS), Acta Obstet Gynecol Scand, 91, 3, 10.1111/j.1600-0412.2011.01303.x Lethaby, 2015, Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding, Cochrane Database Syst Rev, CD002126 Campbell, 1999, Non-pharmacologic strategies used by adolescents for the management of menstrual discomfort, Clin J Pain, 15, 313, 10.1097/00002508-199912000-00008 Golomb, 1998, Primary dysmenorrhea and physical activity, Med Sci Sports Exerc, 30, 906 Brown, 2010, Exercise for dysmenorrhoea, Cochrane Database Syst Rev, CD004142 Rezvani, 2013, The effect of aquatic exercises on primary dysmenorrhoea in nonathlete girls, Iran J Nurs Midwifery Res, 18, 378 Proctor, 2002, Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea, Cochrane Database Syst Rev, CD002123 Lee, 2015, Efficacy of the device combining high-frequency transcutaneous electrical nerve stimulation and thermotherapy for relieving primary dysmenorrhea: a randomized, single-blind, placebo-controlled trial, Eur J Obstet Gynecol Reprod Biol, 194, 58, 10.1016/j.ejogrb.2015.08.020 Dawood, 1990, Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen, Obstet Gynecol, 75, 656 Lundeberg, 1985, Relief of primary dysmenorrhea by transcutaneous electrical nerve stimulation, Acta Obstet Gynecol Scand, 64, 491, 10.3109/00016348509156727 Mannheimer, 1985, The efficacy of transcutanesous electrical nerve stimulation in dysmenorrhea, Clin J Pain, 1, 75, 10.1097/00002508-198501020-00004 Santiesteban, 1985, Primary spasmodic dysmenorrhea: the use of TENS on acupuncture points, Am J Acupunct, 13, 35 Lewers, 1989, Transcutaneous electrical nerve stimulation in the relief of primary dysmenorrhea, Phys Ther, 69, 3, 10.1093/ptj/69.1.3 Neighbours, 1987, Transcutaneous electrical nerve stimulation for pain relief in primary dysmenorrhea, Clin J Pain, 3, 17, 10.1097/00002508-198703010-00004 Smith, 2011, Acupuncture for primary dysmenorrhoea, Cochrane Database Syst Rev, CD007854 Smith, 2016, Acupuncture for dysmenorrhoea, Cochrane Database Syst Rev, CD007854 Chung, 2012, Acupoint stimulation intervention for people with primary dysmenorrhea: systematic review and meta-analysis of randomized trials, Complement Ther Med, 20, 353, 10.1016/j.ctim.2012.02.008 Sriprasert, 2015, Efficacy of acupuncture versus combined oral contraceptive pill in treatment of moderate-to-severe dysmenorrhea: a randomized controlled trial, Evid Based Complement Alternat Med, 2015, 735690, 10.1155/2015/735690 Denny, 1981, Behavioural treatments for primary dysmenorrhea: a review, Behav Res Ther, 19, 303, 10.1016/0005-7967(81)90051-6 Proctor, 2007, Behavioural interventions for primary and secondary dysmenorrhoea, Cochrane Database Syst Rev, CD002248 Akin, 2001, Continuous low-level topical heat in the treatment of dysmenorrhea, Obstet Gynecol, 97, 343 Navvabi Rigi, 2012, Comparing the analgesic effect of heat patch containing iron chip and ibuprofen for primary dysmenorrhea: a randomized controlled trial, BMC Womens Health, 12, 25, 10.1186/1472-6874-12-25 Akin, 2004, Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhea, J Reprod Med, 49, 739 Chaudhuri, 2013, A randomised controlled trial of exercise and hot water bottle in the management of dysmenorrhoea in school girls of Chandigarh, India, Indian J Physiol Pharmacol, 57, 114 Shirvani, 2015, The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial, Arch Gynecol Obstet, 291, 1277, 10.1007/s00404-014-3548-2 Ozgoli, 2009, Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea, J Altern Complement Med, 15, 129, 10.1089/acm.2008.0311 Jenabi, 2013, The effect of ginger for relieving of primary dysmenorrhoea, J Pak Med Assoc, 63, 8 Daily, 2015, Efficacy of ginger for alleviating the symptoms of primary dysmenorrhea: a systematic review and meta-analysis of randomized clinical trials, Pain Med, 16, 2243, 10.1111/pme.12853 Rahnama, 2012, Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial, BMC Complement Altern Med, 12, 92, 10.1186/1472-6882-12-92 Pattanittum, 2016, Dietary supplements for dysmenorrhoea, Cochrane Database Syst Rev, CD002124 Leyland, 2010, SOGC. Endometriosis: diagnosis and management, J Obstet Gynaecol Can, 32, S1 Marcoux, 1997, Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis, N Engl J Med, 337, 217, 10.1056/NEJM199707243370401 Alkatout, 2013, Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial, J Minim Invasive Gynecol, 20, 473, 10.1016/j.jmig.2013.01.019 Johnson, 2004, A double-blind randomised controlled trial of laparoscopic uterine nerve ablation for women with chronic pelvic pain, BJOG, 111, 950, 10.1111/j.1471-0528.2004.00233.x Proctor, 2005, Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea, Cochrane Database Syst Rev, CD001896 Zullo, 2003, Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: a 1-year prospective randomized double-blind controlled trial, Am J Obstet Gynecol, 189, 5, 10.1067/mob.2003.358 Zullo, 2004, Long-term effectiveness of presacral neurectomy for the treatment of severe dysmenorrhea due to endometriosis, J Am Assoc Gynecol Laparosc, 11, 23, 10.1016/S1074-3804(05)60005-9 Berner, 2015, Pain reduction after total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy among women with dysmenorrhoea: a randomised controlled trial, BJOG, 122, 1102, 10.1111/1471-0528.13362 Wallace, 2016, Outcomes and postoperative complications after hysterectomies performed for benign compared with malignant indications, Obstet Gynecol, 128, 467, 10.1097/AOG.0000000000001591 Latthe, 2007, Surgical interruption of pelvic nerve pathways in dysmenorrhea: a systematic review of effectiveness, Acta Obstet Gynecol Scand, 86, 4, 10.1080/00016340600753117 Preutthipan, 2010, Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea, J Obstet Gynaecol Res, 36, 1031, 10.1111/j.1447-0756.2010.01251.x